Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Benhattar

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Gastroenterology|March 23, 2002
p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagusYan-Song Bian, Maria-Chiara Osterheld, Charlotte Fontolliet, et al.
Journal of Ovarian Research|July 12, 2019
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell linesLorena Losi, Angela Lauriola, Erica Tazzioli, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 14, 2012
An unusual uterine tumor with signet ring cell featuresRossella Sarro, Maryse Fiche, Bettina Bisig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluidsStéphanie Bougel, Benoit Lhermitte, Gabrielle Gallagher, et al.
Diagnostic Cytopathology|August 31, 2002
Application of molecular genetics to the diagnosis of lymphoid-rich effusions: study of 95 cases with concomitant immunophenotypingAnca Mihaescu, Sandra Gebhard, Pascal Chaubert, et al.
Cancer Investigation|June 28, 2008
Heterogeneity of human glioblastoma: glutathione-S-transferase and methylguanine-methyltransferaseLucienne Juillerat-Jeanneret, Catherine Chapuis Bernasconi, Charlotte Bricod, et al.
Pathology|October 9, 2020
TERT promoter methylation and protein expression as predictive biomarkers for recurrence risk in patients with serous borderline ovarian tumoursLorena Losi, Laura Botticelli, Lorella Garagnani, et al.
The Journal of Pathology|October 7, 2009
PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cellsStéphanie Bougel, Stéphanie Renaud, Richard Braunschweig, et al.
Nucleic Acids Research|October 27, 2007
Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factorsStéphanie Renaud, Elena M Pugacheva, M Dolores Delgado, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2007
SYT-SSX fusion is absent in sarcomatoid mesothelioma allowing its distinction from synovial sarcoma of the pleuraNicolas Weinbreck, Jean Michel Vignaud, Hugues Begueret, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Gastroenterology|March 23, 2002
p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagusYan-Song Bian, Maria-Chiara Osterheld, Charlotte Fontolliet, et al.
Journal of Ovarian Research|July 12, 2019
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell linesLorena Losi, Angela Lauriola, Erica Tazzioli, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 14, 2012
An unusual uterine tumor with signet ring cell featuresRossella Sarro, Maryse Fiche, Bettina Bisig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluidsStéphanie Bougel, Benoit Lhermitte, Gabrielle Gallagher, et al.
Diagnostic Cytopathology|August 31, 2002
Application of molecular genetics to the diagnosis of lymphoid-rich effusions: study of 95 cases with concomitant immunophenotypingAnca Mihaescu, Sandra Gebhard, Pascal Chaubert, et al.
Cancer Investigation|June 28, 2008
Heterogeneity of human glioblastoma: glutathione-S-transferase and methylguanine-methyltransferaseLucienne Juillerat-Jeanneret, Catherine Chapuis Bernasconi, Charlotte Bricod, et al.
Pathology|October 9, 2020
TERT promoter methylation and protein expression as predictive biomarkers for recurrence risk in patients with serous borderline ovarian tumoursLorena Losi, Laura Botticelli, Lorella Garagnani, et al.
The Journal of Pathology|October 7, 2009
PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cellsStéphanie Bougel, Stéphanie Renaud, Richard Braunschweig, et al.
Nucleic Acids Research|October 27, 2007
Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factorsStéphanie Renaud, Elena M Pugacheva, M Dolores Delgado, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2007
SYT-SSX fusion is absent in sarcomatoid mesothelioma allowing its distinction from synovial sarcoma of the pleuraNicolas Weinbreck, Jean Michel Vignaud, Hugues Begueret, et al.
Pageof 6